Controlled Substance Compliance | B2B Only

Pharmaceutical-Grade Cannabis Trade Facilitation

Aarav Broking facilitates Africa-to-Europe and approved international B2B trade corridors, connecting GACP-certified, government-licensed medical cannabis and pharmaceutical hemp suppliers with EU licensed pharmaceutical importers, EU-GMP medical companies, extraction companies, and pharmaceutical wholesale distributors.

I Am a Supplier I Am a Buyer

Who We Are

Compliance-first pharmaceutical trade facilitation.

Aarav Broking acts only as a trade facilitator and mandate broker. We operate under signed mandate agreements and do not handle, store, process, transport, import, export, or take custody of any physical product.

Our role is to qualify licensed parties, coordinate regulated documentation, support commercial negotiation, and keep introductions aligned with the applicable licence framework in each jurisdiction.

Licence verificationSupplier licences are checked directly with issuing authorities before commercial engagement proceeds.

Regulated corridorsSource and buyer markets are mapped against national narcotics legislation and pharmaceutical import controls.

Commission-only modelRevenue is generated only on confirmed shipments, typically 2-5% of deal value under agreed mandate terms.

How It Works

Structured access for licensed operators.

For Suppliers

GACP-certified African cultivators gain structured access to licensed pharmaceutical buyers and medical companies across Europe.

Supplier qualification and licence review
Buyer-side requirement matching
Commercial mandate representation

Our Role

We coordinate the middle layer of qualification, documentation, and commercial process.

GACP, EU-GMP, CoA and batch record coordination
Import and export permit workflow support
NDA, NCNDA and negotiation support

For Buyers

EU licensed importers and medical companies receive pre-qualified supply options aligned with pharmaceutical documentation expectations.

Supplier and batch documentation screening
Source-country licence and permit coordination
Confidential mandate-based introductions

Products We Facilitate

Pharmaceutical commodity categories.

GACP

GACP Dried Medical Flower

Commercial terms shared only after licence verification.

Trial volumes by mandate

Supplier licence and GACP documentation required before buyer presentation.

GACP

GACP Cannabis Biomass

Offer details subject to documentation and buyer qualification.

Volume by buyer requirement

For licensed EU-GMP extraction companies and qualified pharmaceutical processors.

EU-GMP

EU-GMP Medical Flower

Pricing discussed under NDA / NCNDA only.

Batch availability by mandate

EU-GMP status checked against the EudraGMDP public database.

THC <0.3%

Industrial Hemp Biomass

Commercial details provided after compliance screening.

Volume by licensed use case

For pharmaceutical hemp and industrial processing use, subject to national limits.

CoA Required

CBD Extract / Distillate

Terms available only for qualified licensed operators.

Batch-specific mandate

CoA, batch records and extraction compliance documentation required.

Mandate Only

Custom Licensed Mandate

Structured mandate; no public pricing.

NDA / NCNDA first

Structured sourcing for licensed pharmaceutical buyers with specific grade requirements.

Source Countries

Licensed supply corridors.

Country	Licence Authority / Regulator	Best Product Fit
🇱🇸 Lesotho	Ministry of Health / national controlled medicines licensing framework	GACP dried medical flower, GACP cannabis biomass
🇿🇼 Zimbabwe	Medicines Control Authority of Zimbabwe and national agriculture licensing channels	GACP cannabis biomass, pharmaceutical hemp cultivation
🇲🇼 Malawi	Cannabis Regulatory Authority and national permit framework	Industrial hemp biomass, GACP cultivation projects
🇿🇦 South Africa	SAHPRA and national controlled substance compliance channels	EU-GMP pathways, extraction inputs, controlled substance permit coordination
🇲🇰 North Macedonia	Ministry of Health / Agency for Medicines and Medical Devices framework	EU-GMP medical flower, CBD extract / distillate
🇵🇹 Portugal	INFARMED	EU-GMP medical flower, EU pharmaceutical distribution
🇨🇴 Colombia	National medical cannabis licensing and export permit framework	CBD extract / distillate, GACP biomass

Buyer Markets

Importer qualification by regulator.

Market	Regulatory Body	Buyer Requirements
Germany	BfArM	Import licence, narcotics handling licence, pharmaceutical wholesale distribution authorisation.
United Kingdom	MHRA	Import permissions, controlled substance handling approval, WDA where applicable.
Netherlands	BPMO	National import authorisation, controlled substance compliance, qualified pharmaceutical distribution status.
Denmark	DKMA	Import licence, controlled medicines handling authorisation, pharmaceutical wholesale authorisation.
Switzerland	Swissmedic	Swissmedic-compliant import and distribution authorisations.
Portugal	INFARMED	Pharmaceutical import and distribution authorisation, controlled substance permits where applicable.
Poland	URPL	Import licence, WDA, and national controlled substance documentation.

Compliance Commitment We work exclusively with licensed operators. Every licence is verified directly with the issuing regulatory authority before we proceed.

We do not engage with unlicensed or non-pharmaceutical operators under any circumstances. GACP certificates are verified with recognised auditing firms including IQVIA, Eurofins and SGS where applicable. EU-GMP status is verified using the EudraGMDP public database before buyer-side presentation.

Enquiry Form

Licensed operator intake.

All enquiries are screened for licence status before any commercial discussion. Submissions are treated as confidential and subject to NDA / NCNDA documentation before mandate exchange.

Enquiries are sent to aaravbroking@zohomail.in for controlled documentation review.